Intuitive Surgical (NasdaqGS:ISRG) received FDA clearance for its da Vinci 5 system to be used in certain cardiac procedures.

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Intuitive Surgical, Inc. ISRG is expected to grow earnings by the double digits in 2026 and 2027. This Zacks Rank #1 (Strong Buy) is still the industry leader in robotic-assisted surgery. Intuitive ...

We recently compiled a list of the 20 Most Profitable Stocks of the Last 20 Years. Intuitive Surgical, Inc. is one of the ...

Intuitive Surgical received FDA clearance for its da Vinci 5 system in selected cardiac procedures, including mitral valve repair and cardiac revascularization. The approval enables minimally invasive ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving greater utilization than the earlier Xi model.

Investing.com -- TD Cowen initiated coverage of Intuitive Surgical with a Buy rating and a $660 price target, saying the launch of the da Vinci 5 system is driving a long-tailed product cycle that can ...

Intuitive CEO Dave Rosa highlighted that the clearance related to “several cardiac” procedures for non-force instruments used ...

Intuitive, a leader in robotic-assisted surgery (RAS), announced two studies showing that RAS improves access to high-quality care and enhances patient outcomes, particularly in areas with limited ...

Dan Larson, a Seattle resident diagnosed with lung cancer in 2023, benefited from robotic-assisted surgery developed by Intuitive, a leader in robotic surgical technology. After undergoing two robotic ...